首页> 外文期刊>The journal of immunology >Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses
【24h】

Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses

机译:牛痘病毒特异的CD4 + T细胞反应靶向一组与CD8 + T细胞反应靶向的抗原截然不同的抗原

获取原文
获取外文期刊封面目录资料

摘要

Recent studies have defined vaccinia virus (VACV)-specific CD8+ T cell epitopes in mice and humans. However, little is known about the epitope specificities of CD4+ T cell responses. In this study, we identified 14 I-Ab-restricted VACV-specific CD4+ T cell epitopes by screening a large set of 2146 different 15-mer peptides in C57BL/6 mice. These epitopes account for ~20% of the total anti-VACV CD4+ T cell response and are derived from 13 different viral proteins. Surprisingly, none of the CD4+ T cell epitopes identified was derived from VACV virulence factors. Although early Ags were recognized, late Ags predominated as CD4+ T cell targets. These results are in contrast to what was previously found in CD8+ T cells responses, where early Ags, including virulence factors, were prominently recognized. Taken together, these results highlight fundamental differences in immunodominance of CD4+ and CD8+ T cell responses to a complex pathogen.
机译:最近的研究在小鼠和人类中确定了牛痘病毒(VACV)特异性CD8 + T细胞表位。但是,关于CD4 + T细胞反应的表位特异性知之甚少。在这项研究中,我们通过在C57BL / 6小鼠中筛选了2146种不同的15-mer肽,确定了14种I-Ab限制性VACV特异性CD4 + T细胞表位。这些表位约占抗VACV CD4 + T细胞总应答的约20%,来自13种不同的病毒蛋白。令人惊讶的是,鉴定出的CD4 + T细胞表位都不来自VACV毒力因子。尽管可以识别早期的Ag,但晚期的Ags最主要是CD4 + T细胞靶标。这些结果与以前在CD8 + T细胞反应中发现的结果相反,在CD8 + T细胞反应中,早期Ags(包括毒力因子)得到了公认。综上所述,这些结果突显了CD4 +和CD8 + T细胞对复杂病原体反应的免疫优势方面的根本差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号